Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06261359
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2024-02-07
Brief Title:
A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co Ltd
Organization Data
Organization:
Qilu Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
CEND1-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None